AzTrials
AzTrials

Parental StressNCT04377074

Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety

An observational study of Parental Stress and Depression, run by University of Oslo at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study seeks to investigate the levels of parental stress across different demographic subgroups in the general parental population during the strict social distancing government-initiated non-pharmacological interventions (NPI's) related to the COVID-19 pandemic. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Parental Stress, Depression, Anxiety
How many people
2,880 participants
Where
1 siteNorway
Study dates
31 Mar 2020to 7 Apr 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: The general population of parents (Age >= 18) from all regions (i.e., counties) of Norway, having equal opportunity and the probability of partaking in the study.

Who may be able to join

  • Eligible participants are all parents (over 18 years) living with one or more child under 18 years, and/or a child over 18 with special needs (i.e. physical disabilities). All participants are currently living in Norway and thus experiencing identical NPIs, and who had provided digital consent to partake in the study.
  • How the participants were reached:
  • Given the time-sensitivity of the project and the strict and time-consuming process of getting approval to access registry data, the investigators did not apply for access to registry data (e.g., address, phone or e-mails of the general population), as such data access is highly strict and regulated in Norway and the time-frame of such an application could have encompassed variation in an important variable we wished to hold constant (namely identical NPIs (non-pharmacological interventions) employed over the time-frame of data collection). Thus, the investigators did not apply for registry data, reached out the population through the means elaborated below. The investigators reached out to the general Norwegian population systematically in the following six ways, with the goal of providing the entire adult population an equal opportunity to be exposed to the survey:
  • Through broadcasting on the main national news channel of Norway which had nearly 1.1 million viewers at the time of broadcast.
  • Using Facebook Business Advertisement where we exposed all adult Norwegian Facebook users (3.6 million; 85% of the Norwegian adult population) with an equal opportunity of being exposed to the survey in a random manner. Our survey reached a random selection of nearly 180 000 of the adult population.
  • Broadcasting the survey on national and region radio stations across the country
Show all 9Show fewer
  • Broadcasting about the survey on local radio stations across the country
  • Using national newspaper to reach out to participants about the survey
  • Using regional and local newspapers to reach out to participants across all regions and counties in Norway.

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • University of Oslo

    Oslo

Other trials in Norway

About this study

Official title: Parenting in a Pandemic: Parental Stress During the COVID-19 and Its Association With Depression and Anxiety

This study seeks to investigate the levels of parental stress across different demographic subgroups in the general parental population during the strict social distancing government-initiated non-pharmacological interventions (NPI's) related to the COVID-19 pandemic. The study also seeks to examine the predictors of parental stress rates related to these non-pharmacological interventions (NPI's). In addition, the research will investigate the association between parental stress associated and psychopathology symptoms (i.e., depression and generalized anxiety).

The aim of the project is to:

  • Inform the policymakers, the general public, scientists, and health practitioners about the psychological associations of the COVID-19-related government-initiated measures on parental stress, with special focus on the school and kindergarten lockdowns.
  • Provide a foundation for policymakers and health-care professionals to employ interventions that protect families against possibly increased psychological stressors.
  • Help policymakers and healthcare professionals to better understand the association of demographic variables and other predictors on parental stress and parent-child dysfunction, which information necessary for evaluating the psychological impact of NPIs on parental stress and thus the framework under which decisions about school/kindergarten lockdowns are made.
Read the detailed description

This study seeks to investigate the levels of parental stress across different demographic subgroups in the general parental population during the strict social distancing government-initiated non-pharmacological interventions (NPI's) related to the COVID-19 pandemic, including school and kindergarten lockdown. The study also seeks to examine the predictors of parental stress rates related to these non-pharmacological interventions (NPI's). In addition, the research will investigate the association between parental stress and psychopathology symptoms (i.e., depression and generalized anxiety) during the social distancing interventions.

The aim of the project is to:

  • Inform the policymakers, the general public, scientists, and health practitioners about the psychological associations of the COVID-19-related government-initiated measures on parental stress, with special focus on the school and kindergarten lockdowns.
  • Provide a foundation for policymakers and health-care professionals to employ interventions that protect families against possibly increased psychological stressors.
  • Help policymakers and health-care professionals to better understand the association of demographic variables and other predictors on parental stress and parent-child dysfunction, information necessary in evaluating the psychological impact of social distancing measures on parental stress and thus the framework under which decisions about school/kindergarten lockdowns are made.

Hypothesis/Research Questions Hypothesis related to parental stress during the COVID-19 pandemic

  1. H1: Gender (female), higher age, higher number of children, and having a pre-existing psychiatric diagnosis will be associated with more parental distress.
  2. We assume to find differences in parenting stress during the COVID-19 pandemic based on the existing literature on gender differences on parental behavior and distress (Scott \& Alwin, 1989; Hildingsson \& Thomas, 2013; Deater-Deckard \& Scarr, 1996; McBride et al., 2002; Skari et al., 2002). The literature further suggests that higher age and higher number of children is associated with higher parental stress (Lavee et al., 1996; Östberg \& Hagekull, 2000). Psychopathology symptoms, as reflected by having a pre-existing psychiatric diagnosis, is also found to be associated with parental stress (Pripp et al., 2010; Crugnola et al., 2016; Vismara et al., 2016; Leigh \& Milgrom, 2008; Prino et al., 2016; Rollé et al., 2017).
  3. H2: Worry and rumination in general, low self-efficacy, difficulty with working from home, burnout, low social support, and higher anger expression related to children are all associated with more parental distress, when age, number of children, gender and pre-existing psychiatric diagnosis are controlled for.
  4. Existing research literature have highlighted that perceived personal control is found to be directly related to parental stress (Guterman, 2009), and that women's levels of parental stress is related to parenting self-efficacy (Suzuki, 2010). Sepa and colleges (2004) also reported that lack of confidence/security were linked to parental stress. Reduced social support is also found to be associated with higher rates of parental stress (Östberg \& Hagekull, 2000; Crnic et al., 1983; Suzuki, 2010; Koeske \& Koeske, 1990; Sepa et al., 2004). Furthermore, anger expression is also found to be associated with parental stress in the existing research literature (Lam, 1999). We also hypothesize that burnout, worry and rumination in general and difficulty with working from home will be associated with higher parental stress, relations not previously explored in the existing literature.
  5. H3: More parental distress will be associated with more depressive symptoms and anxiety symptoms, when gender, pre-existing psychiatric diagnosis, age and number of children are controlled for.
  6. Previous studies have found that parents with psychological problems, such as depression and generalized anxiety disorder, are at greater risk for parenting stress, and that parental stress may result in depression and anxiety (Pripp et al., 2010; Crugnola et al., 2016; Vismara et al., 2016; Leigh \& Milgrom, 2008; Prino et al., 2016; Rollé et al., 2017).

Exploratory: Additionally, we will investigate the differences in levels of parental distress across different demographic subgroups in the sample.

Participants were asked to fill out a set of validated questionnaires including demographic variables, psychological symptoms, situational factors related to the consequences of the COVID-19 virus, personality-trait and, and worry, in a random order. Some questionnaires are given as a whole, whereas other questions include theoretically driven selections of items from validated questionnaires, based on a panel of clinical experts, with the goal of avoiding topological overlap. This study is part of a 'The Norwegian COVID-19, Mental Health and Adherence Project' involving multiple studies. In order to not overwhelm and burden the participants with long questionnaire, and due to the mentioned empirical concerns of topological overlap (i.e., overlap in item content) between similar items (for network analysis purposes), in some scales involving large item-content overlap, single items were chosen in a theory-driven manner by three independent clinical psychologists and clinical specialists in adult psychopathology.

Data collection started during the time-period with the strictest and equal number of government-initiated non-pharmacological interventions (NPI's) in Norway, and data collection was stopped once these NPI's were modified or new information about NPI's were added. The data include one directly identifiable variable (contact information) for participants in accordance to the General Data Protection Regulation (GDPR) law in EU, which is to give the participants the opportunity to have their data deleted upon request. Data are thus kept on a safe server belonging to the University of Oslo and will be accessed first following de-identification. Stopping rule for data collection: Stopping rule: 1) At once if government-initiated NPI's are modified or novel information are given about NPIs (to control for cognitive variables) and/ or 2) once we reach enough participants given the power analysis.

Measures: PHQ-9; GAD-7; parental stress; demographic variables (gender; age; civil status; employment status; education level; number of children in household); situational variables (difficulty to work from home; burnout; anger expression related to children; social support; worried or ruminated on problems); person-trait variables (self-efficacy ("I can always manage to solve difficult problems if I try hard enough) and whether one has a psychiatric diagnosis or not. The self-efficacy item is chosen from The General Self-Efficacy Scale (Tambs \& Røysamb, 2014). The parental stress subscale is based on three items from the Danish Parental Stress Scale (Potoppidan et al., 2018).

The outcome variables are Parental Stress, consisting of a total score of parental stress based on items from the Danish parental stress scale; PHQ-9; GAD-7. The other variables are predictors of these three outcome variables. For the parental stress regression analyses we will include the following variables: age, gender, number of children in household, psychiatric diagnosis, difficulty to work from home, worry and rumination; anger expression related to children, social support and self-efficacy. The other two multiple regression analysis will investigate whether parental stress is associated with depression and anxiety symptoms while controlling for the following variables: gender, age, number of children in household and psychiatric diagnosis.

Inference criteria:

Given the large sample size, the investigators pre-defined our significance level:

p< 0.01 to determine significant.

Sample size estimation:

The mentioned 'Norwegian COVID-19, Mental Health and Adherence Project' involves multiple studies, where some involve a Complex Systems (Network analysis) approach. These mutlivariate analyses require large samples and power analysis was conducted accordingly. Following power analysis guidelines by Fried \& Cramer (2017), it is recommended that the number of participants be at the very least three times larger than the number of estimated parameters. However, more conservative recommendations by Roscoe (1975) for multivariate research, recommends sample size that is ten times larger than the number of estimated parameters. Thus, with the more conservative estimates by Roscoe, an optimal sample size for the specific study on parents included more than 2530 individuals. According to the stopping rule mentioned above, due to the importance of keeping the NPI variable constant, we would stop data collection even if we did not obtain our target N. Fortunately, sufficient sample was reached during a period with identical NPIs across the country.

Statistical analyses:

Three multiple regression analysis will be conducted; one with parental stress; the second and third with PHQ-9 and GAD total scores as dependent variables. Specific predictors for these three multiple regression analyses are listed above (hypothesis section). Multicollinarity and other assumptions will be checked; if the multicollinearity is violated (if VIF > 5 and Tolerance > 0.2; Hocking, 2003); O'Brian, 2007).

Note that this the project outline, study plan and analysis was registered upon application to the Regional Committees for Medical and Health Research Ethics (REC) and Norwegian Centre for Research Data 10 days prior data collection, two committees which evaluate the rational for data collection and hypotheses as well as evaluate the ethical aspects of the study before allowing the data to be collected. The study is registered on clinicaltrials.gov after completed data collection, although this registration is prior to any analysis of the data.

Keywords
COVID-19, Parental Stress, Social distancing, Quarantine, Isolation, Non-pharmacological interventions, Disease containment strategies, Depression, Anxiety, Worry
Medical subject headings
Depression, Anxiety Disorders, COVID-19

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure of parental stress

    Three items from the Danish Parental Stress Scale (PSS) was selected, which intends to be a short measure of perceived stress resulting from being a parent (Pontoppidan et al., 2018). The scale consists of nine items measuring parental stress where each is measured on a five-point Likert scale (1-5), with the scores ranging from 3 to 15. Higher scores indicate higher parental stress. The following three were chosen in this large-scale investigation: 1) I feel overwhelmed by the responsibility of being a parent. 2) The major source of stress in my life is my child(ren), and 3) It is difficult to balance different responsibilities because of my child(ren) (Pontoppidan et al., 2018).

    Measured: All data was collected between March 31st 2020 and April 7th 2020, a period where the NPIs (nonpharmacological interventions) against the COVID-19 pandemic were identical and constant in Norway

  2. Patient Health Questionnaire 9

    The Patient Health Questionnaire 9 (PHQ-9; Kroenke, Spitzer \& Williams, 2001) is used to measure symptoms of depression in accordance with the diagnostic criteria for major depressive disorder. The questionnaire consists of nine items where each is scored on a four-point Likert scale (0-3), with the range of scores from 0 to 27. Higher scores indicate greater depression severity, and scores above 10 are considered as the cut-off that indicating that the patient is within the depressive area.

    Measured: All data was collected between March 31st 2020 and April 7th 2020, a period where the NPIs (nonpharmacological interventions) against the COVID-19 pandemic were identical and constant in Norway

  3. Generalized Anxiety Disorder 7

    The Generalized Anxiety Disorder 7 (GAD-7; Spitzer, Kroenke, Williams \& Löwe, 2006) is a questionnaire consisting of seven items measuring symptoms of anxiety and worry. The items are scored on a four-point Likert scale (0-3), with the scores ranging from 0 to 21. Higher scores indicate greater anxiety severity, and scores that are above the cutoff of 10 are considered to be in the clinical range (Spitzer et al., 2006). Specific cut-off for Norwegian samples have been found yielding a cut-off of 8 and above for high sensitivity and specificity (Johnson, Ulvenes, Øktedalen \& Hoffart, 2019).

    Measured: All data was collected between March 31st 2020 and April 7th 2020, a period where the NPIs (nonpharmacological interventions) against the COVID-19 pandemic were identical and constant in Norway

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2020
  2. Study start31 Mar 2020
  3. Primary completion7 Apr 2020
  4. Study completion7 Apr 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
2,880 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04377074
Sponsor's protocol ID
REK125510(3)
Status last verified
May 2020
First submitted
4 May 2020
Last updated
6 May 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Parental Stress and Depression, run by University of Oslo at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure of parental stress (time frame: All data was collected between March 31st 2020 and April 7th 2020, a period where the NPIs (nonpharmacological interventions) against the COVID-19 pandemic were identical and constant in Norway). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in